ALBUTEROL SULFATE | N021457 | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D LLC et al v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al 6 patentsANDA 211600albuterol sulfate | D.N.J. | 2023-10-06 | Terminated 2025-07-29 | — |
| D. Del. | 2017-03-21 | Terminated 2017-11-02 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Teva Pharmaceutical Industries, Ltd. (Teva Respiratory, L.L.C.) - Citizen Pet... FDA-2013-P-0850 · 3 docket documents Teva Respiratory, LLC, a subsidiary of Teva Pharmaceutical Industries Ltd., filed this citizen petition on July 12, 2013, requesting that the FDA refrain from approving any abbreviated new drug application or 505(b)(2) application referencing ProAir HFA (albuterol sulfate) inhalation aerosol as the | 505(q) | 2013-07-25 | Partially Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$1.60
per gm
Lowest NADAC/Unit
$1.60
per gm
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00093317431ALBUTEROL HFA 90 MCG INHALER | $1.60 | GM | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.